CORRELATION BETWEEN HER2 AND EBV EXPRESSION IN GASTRIC CARCINOMA

  • Ljubomir Ognjenovic University Clinic for Abdominal Surgery, Faculty of Medicine “Ss. Cyril and Methodius University”, Skopje, R of North Macedonia
  • Aleksandar Sumkovski University Clinic for Abdominal Surgery, Faculty of Medicine “Ss. Cyril and Methodius University”, Skopje, R of North Macedonia
  • Gjorgi Trajkovski University Clinic for Abdominal Surgery, Faculty of Medicine “Ss. Cyril and Methodius University”, Skopje, R of North Macedonia
  • Jasna Bushinovska University Clinic of Anesthesiology, Reanimation and Intensive Care, Faculty of Medicine “Ss. Cyril and Methodius University”, Skopje, R of North Macedonia
  • Dragan Hadzi-Manchev University Clinic for Abdominal Surgery, Faculty of Medicine “Ss. Cyril and Methodius University”, Skopje, R of North Macedonia
  • Darko Dzambaz University Clinic for Abdominal Surgery, Faculty of Medicine “Ss. Cyril and Methodius University”, Skopje, R of North Macedonia

Abstract

The understanding of the etiopathogenesis and the molecular basis of gastric carcinoma will facilitate the development of novel molecular target therapies, which interfere with different signal cascades involved in cellular proliferation, differentiation and survival.The aim of this paper was to determine the correlation between HER2 and EBV expression in patients with gastric carcinomas. Eighty patients with gastric carcinoma surgically treated were included in the study. Data of HER2 protein expression were obtained from the archive histopathological reports of the Institute of Pathology in Skopje. For detection of EBV, immunostainings were performed on tumor tissue and the peripheral nontumor gastric mucosa.The results of this study confirmed significant association between HER2 and EBV expression (p=0.041). The value of the Spearman correlation coefficient (R = - 0.258) indicated a negative, indirect connection of HER2 and EBV expression, that was confirmed as statistically significant (p = 0.02 levels). The intensity of HER2 expression in gastric carcinomas was significantly associated with EBV expression.


 Key words:gastric carcinoma, HER2, EBV, immunohistochemistry.

References

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55:74–108.
2. Lee HE, Chae SW, Lee YJ, et al. Prognostic implications of type and density of tumor-infiltrating lymphocytes in gastric cancer. BJC. 2008; 99:1704-11.
3. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011; 61:69- 90.
4. Murphy G, Pfeiffer R,Constanza Camargo CM, Rabkin C. Metaanalysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic Location. Gastroenterology. 2009; 137:824–33.
5. Truong CD, Feng W, Li W, Khoury T, Li Q, Alrawi S, Yu Y, Xie K, Yao J, Tan D. Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. Exp Clin Cancer Res. 2009; 28:14.
6. Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Annals of Oncology. 2008; 19:1523–9.
7. Zhou F, Li N, Jiang W, et al. Prognosis significance of HER 2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial. World J Surg Oncol. 2012; 10:274.
8. Jin Z, Jiang W, Wang L. Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review). Oncology Letters. 2015; 9:1502-8.
9. Schuell B, Gruenberger T, Scheithauer W, et al. HER 2/neu protein expression in colorectal cancer. BMC Cancer. 2006; 8(6):123.
10. Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: An update. World J Gastroenterol. 2016; 22(19):4619-25.
11. Sakai K, Mori S, Kawamoto T, et al. Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas. J Natl Cancer Inst. 1986; 77:1047-52.
12. Garcia I, Vizoso F, Martin A, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol. 2003; 10:234-41.
13. Terashima M, Kitada K, Ochiai A, et al. ACTS GC Group: Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res. 2012; 18:5992- 6000.
14. Kono K, Takahashi A, Sugai H, at al. Dendritic Cells Pulsed with HER-2/neu-derived Peptides Can Induce Specific T-Cell Responses in Patients with Gastric Cancer. Clin Cancer Res. 2002; 8:3394–400.
15. Kim JY, Jeon TJ, Bae BN, et al. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma. APMIS. 2013; 121:95 -104.
16. Hofmann M, Stoss O, Shi D, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. 2008; 52(7):797-805.
17. Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012; 2012:743193.
18. Reichelt U, Duesedau P, Tsourlakis MCh, et al. Frequent homogenous HER-2 amplification in primary and metastatic adenocarcinomas of the esophagus. Mod Path. 2007; 20(1):120-9.
19. Kim Y, Shin A, Gwack J, Ko KP, Kim CS, Park SK, Hong YC, Kang D, Yoo KY. Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study. Br J Cancer. 2009; 101(3):526-9.
20. Tokunaga M, Land CE. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomarkers. 1998; 7:449–50.
21. Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol. 2000; 53:255–61.
22. Fukayama M, Hayashi Y, Iwasaki Y, et al. Epstein-Barr virus associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest. 1994; 71:73–81.
23. Burgess DE, Woodman CB, Flavell KJ, et al. Low prevalence of Epstein-Barr virus in incident gastric adenocarcinomas from the United Kingdom. Br J Cancer. 2002; 86:702–4.
Published
2020-07-03
How to Cite
OGNJENOVIC, Ljubomir et al. CORRELATION BETWEEN HER2 AND EBV EXPRESSION IN GASTRIC CARCINOMA. Journal of Morphological Sciences, [S.l.], v. 3, n. 1, p. 97-101, july 2020. ISSN 2545-4706. Available at: <https://jms.mk/jms/article/view/108>. Date accessed: 25 june 2022.
Section
Articles